These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 19956849

  • 21. Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients.
    Wang J, Qin Y, Li B, Sun Z, Yang B.
    Clin Biochem; 2006 Apr; 39(4):344-8. PubMed ID: 16527261
    [Abstract] [Full Text] [Related]

  • 22. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ, Yu GR, Park SH, Cho BH, Ahn JS, Park HJ, Song EY, Kim DG.
    Clin Cancer Res; 2008 Feb 15; 14(4):1080-9. PubMed ID: 18281540
    [Abstract] [Full Text] [Related]

  • 23. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma.
    Kondo Y, Kanai Y, Sakamoto M, Mizokami M, Ueda R, Hirohashi S.
    Hepatology; 2000 Nov 15; 32(5):970-9. PubMed ID: 11050047
    [Abstract] [Full Text] [Related]

  • 24. Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma.
    Cheng Y, Zhang C, Zhao J, Wang C, Xu Y, Han Z, Jiang G, Guo X, Li R, Bu X, Wu M, Wei L.
    Exp Mol Pathol; 2010 Feb 15; 88(1):112-7. PubMed ID: 19879258
    [Abstract] [Full Text] [Related]

  • 25. Comparisons for detecting NY-ESO-1 mRNA expression levels in hepatocellular carcinoma tissues.
    Wang XY, Chen HS, Luo S, Zhang HH, Fei R, Cai J.
    Oncol Rep; 2009 Mar 15; 21(3):713-9. PubMed ID: 19212631
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Correlation between methylation profile of promoter cpg islands of seven metastasis-associated genes and their expression states in six cell lines of liver origin.
    Li JL, Fei Q, Yu J, Zhang HY, Wang P, Zhu JD.
    Ai Zheng; 2004 Sep 15; 23(9):985-91. PubMed ID: 15363188
    [Abstract] [Full Text] [Related]

  • 31. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population.
    Tang SH, Yang DH, Huang W, Zhou HK, Lu XH, Ye G.
    Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4171-7. PubMed ID: 16857788
    [Abstract] [Full Text] [Related]

  • 32. Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India.
    Kiran M, Chawla YK, Kaur J.
    Cancer Genet Cytogenet; 2009 Dec 15; 195(2):112-9. PubMed ID: 19963110
    [Abstract] [Full Text] [Related]

  • 33. [Detection of aberrant promoter CpG islands hypermethylation of GSTP1 in human primary hepatocellular carcinomas].
    Wang JH, Qin Y, Li B, Sun ZL, Sun ZF, Guan QL.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep 15; 36(5):686-8. PubMed ID: 16235538
    [Abstract] [Full Text] [Related]

  • 34. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan.
    Hsu LS, Lee HC, Chau GY, Yin PH, Chi CW, Lui WY.
    Oncol Rep; 2006 Feb 15; 15(2):507-11. PubMed ID: 16391877
    [Abstract] [Full Text] [Related]

  • 35. Identification of a non-coding KLF4 transcript generated from intron retention and downregulated in human hepatocellular carcinoma.
    Zhou J, Lai PB, Tsui SK.
    Int J Oncol; 2015 Oct 15; 47(4):1554-62. PubMed ID: 26238073
    [Abstract] [Full Text] [Related]

  • 36. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
    Roncalli M, Bianchi P, Bruni B, Laghi L, Destro A, Di Gioia S, Gennari L, Tommasini M, Malesci A, Coggi G.
    Hepatology; 2002 Aug 15; 36(2):427-32. PubMed ID: 12143052
    [Abstract] [Full Text] [Related]

  • 37. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S, Shiina H, Enokida H, Hirata H, Kawamoto K, Kawakami T, Kikuno N, Tanaka Y, Majid S, Nakagawa M, Igawa M, Dahiya R.
    Clin Cancer Res; 2006 Dec 01; 12(23):6989-97. PubMed ID: 17145819
    [Abstract] [Full Text] [Related]

  • 38. Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma.
    Song J, Kim CJ, Cho YG, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY, Park WS.
    J Gastroenterol Hepatol; 2006 Aug 01; 21(8):1286-9. PubMed ID: 16872311
    [Abstract] [Full Text] [Related]

  • 39. Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma.
    Fukai K, Yokosuka O, Imazeki F, Tada M, Mikata R, Miyazaki M, Ochiai T, Saisho H.
    Liver Int; 2005 Dec 01; 25(6):1209-16. PubMed ID: 16343074
    [Abstract] [Full Text] [Related]

  • 40. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
    Urakami S, Shiina H, Enokida H, Kawakami T, Kawamoto K, Hirata H, Tanaka Y, Kikuno N, Nakagawa M, Igawa M, Dahiya R.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2109-16. PubMed ID: 16609023
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.